Form 4 Tracker
Candel Therapeutics, Inc.
CADL

30 insider filings · Latest: Sep 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 11, 2026Sep 11 10:12 PMPaul Peter TakDirector, Chief Executive Officer
Sale
59,379$10.46$620.9K113,321(D)

View →

Sep 10, 2026Sep 11 10:12 PMPaul Peter TakDirector, Chief Executive Officer
Sale
220,866$11.50$2.5M172,700(D)

View →

Sep 10, 2026Sep 10 8:39 PMPAUL PETER TAK
Proposed Sale
280,245$12.17$3.4M—

View →

Aug 17, 2026Aug 19 8:30 PMSeshu TyagarajanChief Technology Officer
Sale
7,000$12.00$84.0K76,865(D)

View →

Aug 17, 2026Aug 17 8:37 PMSESHU TYAGARAJAN
Proposed Sale
7,000$11.72$82.0K—

View →

Jun 29, 2026Jul 1 8:22 PMFrancesca BaroneChief Scientific Officer
Sale
23,447$10.06$235.8K77,362(D)

View →

Jun 29, 2026Jul 1 8:22 PMSeshu TyagarajanChief Technology Officer
Sale
7,000$10.02$70.2K83,865(D)

View →

Jun 29, 2026Jun 29 8:44 PMSESHU P TYAGARAJAN
Proposed Sale
7,000$9.79$68.5K—

View →

Jun 29, 2026Jun 29 8:41 PMFRANCESCA BARONE
Proposed Sale
23,447$9.79$229.5K—

View →

Feb 23, 2026Feb 27 12:38 AMManning Paul BDirector
Purchase
550,458$5.45$3.0M2,763,527(I)

View →

Jun 30, 2025Jun 30 8:19 PMWILLIAM GARRETT NICHOLS
Proposed Sale
3,593$4.90$17.6K—

View →

Mar 18, 2025Mar 18 8:29 PMFRANCESCA BARONE
Proposed Sale
32,146$8.83$283.8K—

View →

Mar 18, 2025Mar 18 8:29 PMPAUL PETER TAK
Proposed Sale
74,106$8.83$654.4K—

View →

Mar 18, 2025Mar 18 8:28 PMWILLIAM GARRETT NICHOLS
Proposed Sale
45,316$8.83$400.1K—

View →

Mar 17, 2025Mar 17 8:29 PMSESHU TYAGARAJAN
Proposed Sale
31,278$8.75$273.7K—

View →

Mar 17, 2025Mar 17 8:29 PMCHARLES SCHOCH
Proposed Sale
5,000$8.75$43.8K—

View →

Jan 15, 2025Jan 15 1:30 PMTyagarajan Seshu
Proposed Sale
13,177$7.84$103.3K—

View →

Jan 15, 2025Jan 15 1:30 PMSchoch Charles
Proposed Sale
8,751$7.84$68.6K—

View →

Jan 15, 2025Jan 15 1:30 PMBarone Francesca
Proposed Sale
12,452$7.84$97.6K—

View →

Jan 15, 2025Jan 15 1:30 PMNichols William Garrett
Proposed Sale
9,564$7.86$75.2K—

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 31, 2026Apr 2 9:08 PMNicoletta LoggiaDirector
Grant/Award
779$4.90779(D)

View →

Jan 26, 2026Jan 28 10:04 PMSeshu TyagarajanChief Technology Officer
Grant/Award
154,000$6.01154,000(D)

View →

Jan 26, 2026Jan 28 10:03 PMWilliam Garrett NicholsChief Medical Officer
Grant/Award
136,500$6.01136,500(D)

View →

Jan 26, 2026Jan 28 10:02 PMCharles SchochChief Financial Officer
Grant/Award
232,000$6.01232,000(D)

View →

Jan 26, 2026Jan 28 10:01 PMPaul Peter TakDirector, Chief Executive Officer
Grant/Award
629,000$6.01629,000(D)

View →

Jan 26, 2026Jan 28 10:00 PMFrancesca BaroneChief Scientific Officer
Grant/Award
232,000$6.01232,000(D)

View →

← Previous

Page 2 of 2